Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database
This study is called "The International DEM-CHILD Database" and looks at different types of Batten disease, also known as Neuronal Ceroid Lipofuscinosis (NCL). It's an observational study, meaning researchers watch and collect information about how the disease naturally progresses in patients over time. They gather details from medical records, patient questionnaires, and regular check-ups. The aim is to understand how the disease affects things like movement, language, thinking skills, seizures, and eyesight. This information is really important for developing and testing new treatments. The study also collects patient samples to help scientists worldwide research these rare conditions more effectively.
At a glance
What is this study about?
This research project, called the International DEM-CHILD Database, is looking at a group of rare, inherited conditions known as Batten disease, or NCL (Neuronal Ceroid Lipofuscinoses). These conditions cause children and young people to gradually lose skills they've already learned, affecting their movement, thinking abilities, and eyesight. This can lead to problems like difficulty walking, memory issues, blindness, and seizures.
The main goal of this study is to understand the **natural history** of these diseases. This means researchers want to meticulously observe and record how Batten disease develops and changes over time in different individuals, without introducing any new treatments. They collect information from various sources, including existing medical records, questionnaires that patients and their families fill out, and details from routine clinic visits. They pay close attention to how the disease affects key areas like movement, speech, thinking, seizures, vision, and behaviour.
Why is this important? Because Batten disease is rare, its exact course isn't fully understood. By gathering detailed information on how it progresses, scientists can create a clearer picture. This knowledge is crucial for future research because it provides a benchmark to compare new treatments against. If a new experimental treatment is developed, researchers need to know what the disease's typical progression looks like without treatment to see if the new therapy is making a real difference. The study also aims to create a central resource of patient samples, making it easier for scientists all over the world to access materials needed for groundbreaking research into these conditions.
Key takeaways
- This study helps doctors understand Batten disease better.
- It collects information from medical records and regular check-ups.
- No new treatments are given as part of this study.
- The findings will help develop new medicines for Batten disease.
- Participation contributes to global research efforts.
Who may be eligible?
This study is looking for people with any type of Batten disease (NCL).
To join, you must have had a genetic test that clearly shows you have a form of Batten disease. If you have a specific type called CLN2 disease and have been treated with a medicine called cerliponase alpha (also known as Brineura), you can also join.
Even if a patient has sadly passed away, their family can still allow their medical information to be used for the study's past data analysis, as long as the genetic cause of their Batten disease was confirmed. If you don't have a confirmed genetic diagnosis of Batten disease, you won't be able to join this study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do you have a genetically confirmed diagnosis of Batten disease (NCL)?
- If you have CLN2 disease, have you been treated with Brineura (cerliponase alpha)?
- Are you comfortable with your medical information being used for research?
- If you are a family member of a deceased patient, do you have a confirmed genetic diagnosis for their Batten disease?
- Are you based in the UK or another country participating in the DEM-CHILD database?
What does participation involve?
This is an observational study, which means you won't be given any new or experimental treatments as part of this research. Instead, researchers will collect information about your health over time. This information will come from your existing medical records, questionnaires you or your family fill out, and details gathered during your regular clinic appointments. There are no extra visits or special assessments just for this study; it aims to use information from your routine care. The study will continue to collect data for an ongoing period, documenting the long-term progression of the disease. You can decide to stop participating at any time.
Potential risks and benefits
Locations (1)
- University Medical Center Hamburg-EppendorfVerified postcodeHamburg, Germany· Recruiting
Common questions
What is Batten disease?
Batten disease is a group of rare, inherited conditions that affect the brain and nervous system, leading to problems with movement, thinking, and vision.
What does 'natural history' mean in this study?
It means the study observes how Batten disease develops and changes over time without any new treatments being given. Researchers simply track how the condition progresses naturally.
Will I receive any new medicine or treatment by joining this study?
No, this is an observational study, so you will not receive any new or experimental treatments as part of the research itself.
How will my information be used?
Your medical information will be used to understand how Batten disease progresses. This helps scientists develop and test new medicines more effectively, potentially benefiting patients in the future.
Do I need to make extra hospital visits for this study?
No, the study gathers information from your existing medical records and details from your routine clinic visits. You won't need to make any extra trips just for this research.
How to find out more
Miriam Nickel, MD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.